Stocks and Investing
by (remove) : Jason Mills
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Jason Mills
RSSJSONXMLCSV
Thu, August 1, 2024
Wed, May 1, 2024
Tue, April 26, 2022
Wed, July 14, 2021
Thu, May 6, 2021
Wed, March 31, 2021
Mon, October 26, 2020
Thu, August 6, 2020
Thu, April 30, 2020
Tue, April 14, 2020
Mon, April 13, 2020
Thu, April 9, 2020
Wed, April 8, 2020
Tue, April 7, 2020
Mon, November 11, 2019
Thu, June 27, 2019
Tue, May 28, 2019
Wed, April 17, 2019
Mon, January 7, 2019
Thu, October 25, 2018
Tue, October 9, 2018
Thu, September 6, 2018
Wed, August 15, 2018
Tue, July 24, 2018
Mon, June 25, 2018
Thu, June 21, 2018
Thu, May 3, 2018
Mon, April 2, 2018
Tue, February 27, 2018

Jason Mills Maintained (TMDX) at Strong Buy with Increased Target to $169 on, Aug 1st, 2024


Published on 2024-10-28 13:02:26 - WOPRAI, Jason Mills
  Print publication without navigation


Jason Mills of Canaccord Genuity, Maintained "TransMedics Group, Inc." (TMDX) at Strong Buy with Increased Target from $117 to $169 on, Aug 1st, 2024.

Jason has made no other calls on TMDX in the last 4 months.



There are 4 other peers that have a rating on TMDX. Out of the 4 peers that are also analyzing TMDX, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Patrick Wood of "Morgan Stanley" Maintained at Hold with Increased Target to $145 on, Monday, July 15th, 2024


These are the ratings of the 3 analyists that currently disagree with Jason


  • Joshua Jennings of "TD Cowen" Maintained at Strong Buy with Increased Target to $175 on, Friday, June 7th, 2024
  • George Sellers of "Stephens & Co." Initiated at Buy and Held Target at $151 on, Tuesday, June 4th, 2024
  • Allen Gong of "JP Morgan" Maintained at Buy with Increased Target to $127 on, Wednesday, May 1st, 2024
Contributing Sources